Skip to main content

This webpage content is intended for Health Care Professionals (HCP’s) only.

I am not a HCP

Intended for Healthcare Professionals

Johnson and Johnson logo graphic link
/en-EMEA
  • biosense webster logo
  • Cerenovus JJMT logo
  • DePuy Synthes Logo
  • Ethicon Logo
  • mentor logo

Intended for HCPs

Intended for Healthcare Professionals

Secondary nav block

Biosense Webster Logo
  • Products
    • All Products
    • 3D Navigation
    • Therapeutic Catheters
    • Diagnostic Catheters
    • Ultrasound Solutions
    • Access Products
    • Generators
    • Data Solutions
  • Service
  • Research
    • Clinical Evidence
    • Ongoing Studies
    • External Research Partnerships
    • Health Economics Market Access
    • Pulse Field Ablation Evidence
  • Resources
    • EU Medical Devices Regulation
    • J&J Institute
    • Medical Information Request (MIR)
  • News
  • About Us

Biosense Webster News & Events

Biosense Webster Logo

Biosense Webster Completes Enrollment in Pivotal Trial Evaluating PFA and RF Dual Energy Catheter for Patients with Atrial Fibrillation in Europe

19 July 2023
Biosense Webster Logo

Biosense Webster Begins SmartfIRE Clinical Trial to Evaluate its First Dual Energy Catheter to Treat Atrial Fibrillation

07 March 2023
kevin hall selfie with significant other

What AFib patient Kevin Hall wants everyone to know about Atrial Fibrillation

01 November 2022
Biosense Webster Launches HELIOSTAR™ in Europe

Biosense Webster Launches HELIOSTAR™ in Europe, the First Radiofrequency Balloon Ablation Catheter, Enabling Physicians to Perform More Efficient Cardiac Ablations

12 October 2022
biosense webster logo

Biosense Webster Launches the OCTARAY™ Mapping Catheter with TRUEref™ Technology

06 September 2022
The novel HELIOSTAR™ Balloon Ablation Catheter is the first-ever radiofrequency balloon ablation catheter

Biosense Webster Announces Completion of Atrial Fibrillation Cases Using Novel HELIOSTAR™ Balloon Ablation Catheter

28 September 2021
Investigational VARIPULSE™ Catheter and TRUPULSE™ Generator uses pulsed field ablation

Biosense Webster inspIRE Clinical Study Shows 100% Acute Procedural Success in Initial Data

27 August 2021
professor dhiraj gupta

Comparing the Effectiveness of Different Catheter Ablation Technologies to Help Atrial Fibrillation (AF) Patients Live ‘Disease Free’

27 October 2020
CARTO PRIME® Module hero image

Biosense Webster Launches CARTO® 3 System Version 7 and the CARTO PRIME™ Mapping Module to Advance Treatment of Complex Arrhythmias

27 August 2020
QDOT Micro® Catheter hero image

Biosense Webster Receives CE Mark Approval for QDOT MICRO®, The World’s First Very High Power, Short Duration Ablation Catheter

13 August 2020
  • Load More
Johnson and Johnson logo
Johnson & Johnson
  • Privacy Policy
  • Legal Notice
  • Careers
  • J&J Institute
  • Contact
  • Accessibility Statement
  • Cookie Policy
English (EMEA)

You are about to leave jnjmedtech.com. By clicking to continue, you will be taken to a web site governed by their own Legal and Privacy Policies.

Yes, Continue to External Site No, Stay Here